Cutting-edge developments in blood-based biomarkers for Alzheimer’s: an interview with Charlotte Teunissen

Written by Charlotte Teunissen (Amsterdam University Medical Centers, The Netherlands)

Charlotte Teunissen is a Professor in Neurochemistry at Amsterdam University Medical Centers (The Netherlands). She heads a neurochemistry lab that is aimed at developing novel biomarkers in body fluids for the ultimate use to improve care for neurological diseases. The lab focuses on a full coverage of biomarker development, which includes identification, development, clinical validation and implementation. In this interview, Charlotte speaks to us about her plenary lecture from the Alzheimer’s Association International Conference (AAIC; 27–31 July 2020) on blood-based biomarkers. She also discusses how these biomarkers could be regulated and standardized, in addition to providing her input on how...

To view the full article, please register now for access

It's completely free